Dr David Kim. Endocrinologist and General Physician Waitemata DHB and Apollo Specialist Clinic Albany Auckland

Similar documents
Endocrinology Update. Dr Colin Johnston Hon Consultant West Herts Trust

Southern Derbyshire Shared Care Pathology Guidelines. Hyperthyroidism

Requesting and Management of abnormal TFTs.

Update In Hyperthyroidism

Hyperthyroidism Diagnosis and Treatment. April Janet A. Schlechte, M.D.

Lecture title. Name Family name Country

Thyroid Gland. Patient Information

Thyroid. Dr Jessica Triay November 2018

Endocrinology in Primary Care. HN Buch

Understanding thyroid function tests. Dr. Colette George

The Number Games and Thyroid Function Arshia Panahloo Consultant Endocrinologist St George s Hospital

Hyperthyroidism and Hypothyroidism in Pregnancy Guideline

Female Reproductive Endocrinology

Women s Health in General Practice Symposium 2015 Thyroid & Parathyroid Cases

An Approach to: Thyroid Function Tests. Rinkoo Dalan Consultant Department of Endocrinology Tan Tock Seng Hospital

Virginia ACP Clinical Update Thyroid Clinical Pearls. University of Virginia. Richard J. Santen MD

06-Mar-17. Premature menopause. Menopause. Premature menopause. Menstrual cycle oestradiol. Premature menopause. Prevalence ~1% Higher incidence:

Understanding Thyroid Labs

Common Causes of Hypothyroidism

Disorders of Thyroid Function

Effect of thyroid hormones of metabolism Thyroid Diseases

Update on Gestational Thyroid Disease. Aidan McElduff The Discipline of Medicine, The University of Sydney

Some Issues in the Management of Hypothyroidism

Targeted Issues in Endocrinology Joshua S. Coren, DO, MBA, FACOFP

4) Thyroid Gland Defects - Dr. Tara

Hyperthyroidism. Objectives. Clinical Manifestations. Slide 1. Slide 2. Slide 3. Implications for Primary Care. hyperthyroidism

Lothian Guidance for Diagnosis and Management of Thyroid Dysfunction in Pregnancy

Aromatase Inhibitors & Osteoporosis

Alvin C. Powers, M.D. 1/27/06

THYROID DISEASE IN CHILDREN

Thyroid gland defects. Dr. Tara Husain

Common Issues in Management of Hypothyroidism

Dumfries and Galloway. Treatment Protocol for Osteoporosis

Thyroid Disease. I have no disclosures. Overview TSH. Matthew Kim, M.D. July, 2012

GLMS CME- Cell Group 5 10 April Greenlane Medical Specialists Pui-Ling Chan Endocrinologist

THYROID AWARENESS. By: Karen Carbone. January is thyroid awareness month. At least 30 million Americans

Disclosures. Learning objectives. Case 1A. Autoimmune Thyroid Disease: Medical and Surgical Issues. I have nothing to disclose.

THE THYROID BOOK. Medical and Surgical Treatment of Thyroid Problems

CHAPTER-II Thyroid Diseases. by: j. jayasutha lecturer department of Pharmacy practice Srm college of pharmacy srm university

Thyroid Disease in Pregnancy: The Essentials. Elizabeth N. Pearce, MD, MSc

Thyroid Plus. Central Thyroid Regulation & Activity. Peripheral Thyroid Function. Thyroid Auto Immunity. Key Guide. Patient: DOB: Sex: F MRN:

More than meets the eye

Dr John Quin. Royal Sussex County Hospital, Brighton. BHIVA AUTUMN CONFERENCE 2013 Including CHIVA Parallel Sessions. None

Southern Derbyshire Shared Care Pathology Guidelines. Hypothyroidism

Overview of Reproductive Endocrinology

Thyroid disorders. Dr Enas Abusalim

Neonatal Thyrotoxicosis Management of babies born to mothers with a history of hyperthyroidism (Grave s Disease)

Amiodarone Induced Thyrotoxicosis Treatment? (AIT)

university sciences of Isfahan university Com

None. Thyroid Potpourri for the Primary Care Physician. Evaluating Thyroid Function. Disclosures. Learning Objectives

BELIEVE MIDWIFERY SERVICES

NSC 830: Drugs Affecting the Thyroid BROOKE BENTLEY, PHD, APRN

Approach to thyroid dysfunction

AUGUST 25-27, 2017 UPDATE & BOARD REVIEW. acofp INTENSIVE. Evolving Issues in Endocrinology. Chris Pitsch, DO INNOVATIVE COMPREHENSIVE HANDS-ON

Guidance for Thyroid Function Testing in Primary Care in Lothian

OUTLINE. Regulation of Thyroid Hormone Production Common Tests to Evaluate the Thyroid Hyperthyroidism - Graves disease, toxic nodules, thyroiditis

B-Resistance to the action of hormones, Hormone resistance characterized by receptor mediated, postreceptor.

Thyroiditis Diagnosis and Management issues. Prof. Md. Enamul Karim Professor of Medicine Dhaka Medical College

The Presence of Thyroid Autoantibodies in Pregnancy

Who is this leaflet for? What is hyperthyroidism? What is the thyroid gland? What causes hyperthyroidism? How is hyperthyroidism diagnosed?

Endocrinology for Finals. Maralyn Druce Professor of Endocrine Medicine Barts and the London School of Medicine

Diseases of thyroid & parathyroid glands (1 of 2)

Balancing Hormone Function in Women By Meghna Thacker, NMD

Laura Trask, MD FACP Central Maine Endocrinology Lewiston, ME

Lothian Guidance for Diagnosis and Management of Thyroid Dysfunction in Pregnancy.

REFERRAL GUIDELINES ENDOCRINOLOGY

Case Report Recurrent Episodes of Thyrotoxicosis in a Man following Pregnancies of his Spouse with Hashimoto s Thyroiditis

Screening Babies at risk of Congenital Hyperthyroidism GL354

John Sutton, DO, FACOI, FACE, CCD. Carson Tahoe Endocrinology Carson City, NV KCOM Class of 1989

NEWBORN FEMALE WITH GOITER PAYAL PATEL, M.D. PEDIATRIC ENDOCRINOLOGY FELLOW FEBRUARY 12, 2015

HYPERTHYROIDISM. Hypothalamus. Thyrotropin-releasing hormone (TRH) Anterior pituitary gland. Thyroid-stimulating hormone (TSH) Thyroid gland T4, T3

THYROID DISEASES. CASE BASED WORKSHOP Z. Henry He, MD, PhD. Endocrinology, Diabetes, & Metabolism Cambridge Health Alliance Harvard Medical School

Hypothyroidism. Definition:

New Patient Intake Form

Endocrine Case Presentations

Management of Common Thyroid Disorders

Evaluation and Management of Pituitary Failure. Dr S. Ali Imran MBBS, FRCP (Edin), FRCPC Professor of Medicine Dalhousie University, Halifax, NS

Initials:.. Number of patient in the registry:... Date of visit:.. Gender (genetic): female / male

EFFECTIVE SHARE CARE AGREEMENT. For the specialist use of LIOTHYRONINE for patients registered with a Dudley GP.

16 7/12 year old Female with Down s Syndrome and Abnormal TFTs. Moina Uddin, D.O. Endorama 6/26/14

Page 1. Understanding Common Thyroid Disorders. Cases. Topics Covered

Part I Initial Office Visit. Questions NATIONAL CENTER FOR CASE STUDY TEACHING IN SCIENCE

Elements for a Public Summary

Pituitary Case 2. Dr Lydia Lamb Endocrinology Registrar Fiona Stanley Hospital Western Australia

Diabetes Centre. Treatment for Overactive Thyroid Gland. Information

10 Essential Blood Tests PART 2

THE THYROID. Your thyroid evaluation may include the following:

Sample Type - Serum Result Reference Range Units. Central Thyroid Regulation Surrey & Activity KT3 4Q. Peripheral Thyroid D Function mark

Mastering Thyroid Disorders. Douglas C. Bauer, MD UCSF Division of General Internal Medicine

Six Things That Changed How I Manage Graves Disease

Reference intervals are derived from the statistical distribution of values in the general healthy population.

Endocrine Emergencies: Recognition and Management

Dumfries and Galloway. Treatment Protocol for Osteoporosis

DISORDERS OF THE THYROID GLAND SIGNS, SYMPTOMS, & TREATMENT ENDOCRINE SYSTEM AT A GLANCE OBJECTIVES ANATOMY OF THE THYROID

Management of Common Thyroid Disorders

Managing thyrotoxicosis in the acute medical setting

New diagnosis of hyperthyroidism in primary care

TANJA KEMP INTERNAL MEDICINE: ENDOCRINOLOGY

Thyroid Diseases. Q1: The most common thyroid function disorder is? Q2: The most sensitive test for thyroid function is?

Menopause & HRT. Rosie & Alex. Image:

Transcription:

Dr David Kim Endocrinologist and General Physician Waitemata DHB and Apollo Specialist Clinic Albany Auckland 14:00-14:55 WS #40: Endocrine Case Studies 15:05-16:00 WS #52: Endocrine Case Studies (Repeated)

Endocrine Case Studies David Kim Endocrinologist & Physician

Disclosure Nothing to disclose relevant to this presentation (Board member of Osteoporosis New Zealand - not for profit NGO)

Case 1 33 y.o. woman presents tired 4 months history of tremors, palpitations, heat intolerance and 6kg weight loss No significant past medical history, 9 months post partum (G2P2) FHx mother had goitre needing surgery, now on thyroxine O/E: Normal BMI, peripheral tremor, HR 90/min regular, BP 130/70. Thyroid?mildly enlarged, mild tenderness/ discomfort on palpation, no obvious mass/nodule, no audible thyroid bruit

Diagnosis? DDx? probable hyperthyroidism What else would you like to know in the Hx? What are typical thyrotoxic symptoms/ signs? What tests would you order to confirm Dx? T4: 33 pmol/l (10-20), T3: 12 pmol/l (3.0-6.5), TSH: <0.01 mu/l, thyroperoxidase (TPO) antibodies raised in the 100 s

Case 1 Interim Dx: Newly diagnosed hyperthyroidism -?cause DDx : - Graves disease - Post partum or silent thyroiditis - Toxic nodular goitre Other possibilities (but highly unlikely) are: - Subacute (De Quervain s) thyroiditis - Medication/ iodine induced thyrotoxicosis

Hyperthyroidism: Further management and work-up Start carbimazole when? dose? (dose range 5 40 mg a day depending on disease severity) β-blocker when? which? dose? precautions? Repeat thyroid function testing when? Any other tests? Thyroid Stimulating Immunoglobulin (TSI)? Imaging? (e.g. neck ultrasound) Refer to endocrinology? Yes (in most), if uncertainties in initial management, call endocrinologist/ endo registrar to discuss

Hyperthyroidism/ Graves other potential management issues Intolerance to carbimazole (itchy rash most common): - oral antihistamine +/- 1% hydrocortisone cream - consider stopping and switching to propylthiouracil (PTU) If fever/ sore throat (?agranulocytosis) withhold carbimazole/ PTU and do a full blood count ASAP

Hyperthyroidism/ Graves other potential management issues Duration of carbimazole therapy? - Generally 12-18 months, usual maintenance dose ~5-15mg/day (1 2 monthly TFT s) Persistent poor control or recurrent disease: - Generally due to either very active disease or poor compliance/ inadequate dosing - Consider definitive therapy Radioactive iodine (first line Rx in toxic nodular goitre), very occasionally surgery (total thyroidectomy)

Hyperthyroidism/ Graves other potential management issues Graves orbitopathy - Consider referring directly to ophthalmology service if moderate/severe (ocular pain with swelling/redness or diplopia or marked proptosis) - Lubrication (polytears +/- lacrilube), protection (sunglasses, hat) - Smoke cessation

Subclinical hyperthyroidism Biochemical definition: Normal T4 (and T3) & suppressed TSH e.g. T4: 18.0, TSH: <0.01 Mx: Not unreasonable to retest after 1-2 months if asymptomatic with no active cardiac issues, otherwise work-up and treat like mild hyperthyroidism

Case 2 52 y.o. woman presents with tiredness. She also has low mood, few kg weight gain, irregular/ heavy menses O/E: comfortable, BMI 28, generally NAD Labs: normal FBC, U&E, LFT. TFT T4: 8.5 pmol/l (10-20), TSH 25 mu/l (0.3 4.0) Lab test 3 years ago T4: 14, TSH 5.8, thyroid antibodies TPO antibodies strongly +ve, FHx +ve for mother and sister thyroid problem on some tablets Diagnosis?? Primary hypothyroidism - Hashimoto s disease

Hypothyroidism Common problem with prevalence of 3-4% in general population Defined biochemically with low T4 and raised TSH (usually >10 mu/l) Almost always due to Hashimoto s disease Less common causes thyroidectomy, radioactive iodine Rx, medication/iodine induced (amiodarone, lithium), pituitary disease (low TSH)

Hypothyroidism Management Thyroxine 50-100mcg daily (25mcg daily in >80yrs and/or cardiac disease) Repeat TFT 5-6 weeks later to titrate dose - aim for TSH within normal range Usual maintenance dose 100-200mcg daily 6-12 monthly TSH testing once maintenance dose established?whole thyroid extract (T3 containing formulae) not funded, no evidence to support its use

Hypothyroidism other issues/ potential problems Subclinical hypothyroidism (normal T4, raised TSH) what to do and when to treat? If symptomatic, reasonable to treat at any TSH If asymptomatic, reasonable to treat if TSH >10 Intolerant to a particular brand of thyroxine (Eltroxine, Gold Shield, Synthroid) Try a different brand

Hypothyroidism other issues/ potential problems TSH still raised despite high dose (>250mcg/d) Check compliance?other meds (iron/calcium)?strong coffee Consider bedtime dosing Pregnancy TFT testing pre-conception to ensure euthyroid, dose escalation during pregnancy (typically 30-50% increase), keep TSH <2.5 (ignore TSH suppression early pregnancy), regular TFT 2-4 weekly especially in 1 st trimester, less frequent later (~monthly)

Thyroid swelling Goitre/ mass Thyroid mass or asymmetric thyroid enlargement needs proper work-up (hx, exam, TFTs) + USS imaging Symmetrical small/soft goitre often due to underlying thyroid disorder e.g. Hashimoto s or Graves. USS if no obvious cause

Large goitre Causes and work up Causes: - Multinodular goitre - Graves disease/ Hashimoto s disease - Iodine deficiency (exceedingly rare in NZ) Work-up: - Hx -?Duration?FHx?Compressive symptoms - Clinical exam, including?pemberton s sign - TFT, thyroid antibodies, thyroid USS

When to refer to Endo? Unilateral mass or enlarging goitre (get USS before referral) Goitres with compressive symptoms or significant aesthetic concern consider direct referral to surgeons (General surg vs. ORL)

Case 3: Ms EB 46 y.o. woman is tired, saw a naturopath who told her that she had adrenal fatigue and suggested various supplements including AdrenoTone PMHx of migraine, gestational hypertension No regular prescription medications, takes a few supplements (concoction of vitamins and minerals the naturopath recommended) Further history? Exam? investigations?

Case 3: Need to exclude adrenal insufficiency - other medical/ autoimmune history? - family history? - medication history?steroid use - darkening of skin? - blood pressure?postural drop

Case 3: Reports some postural dizziness with no postural BP drop noted in clinic high BP 152/100 No weight loss (in fact, struggling to lose weight), BMI = 31.1 Morning serum cortisol (9am) = 196 nmol/l (mildly low) Serum Na + and K + normal Diagnostic test = synacthen stimulation test not performed (repeat morning cortisol 410 nmol/l + above clinical features)

Refer if genuine adrenal insufficiency suspected e.g. morning serum cortisol <200 with relevant signs and symptoms (weight loss/ low BP/ postural drop/ low sodium Urgent referral to local endocrine service Admit or d/w on-call endocrine team if acutely sick/ febrile Long term management of adrenal insufficiency Hydrocortisone & fludrocortisone Medic-Alert bracelet Sick-day management

Case 4: Ms NC 43 y.o. woman with secondary amenorrhoea 9 years history Normal menarche, normal periods in teens/ 20 s, 2x normal pregnancies in her late 20 s Diagnostic possibilities? Further history and Exam? PCOS? Premature menopause? Pituitary or uterine issue (Pregnancy highly unlikely in this case!)

Case 4 History of amenorrhoea with eating disorder (nadir weight 33kg), resolved current weight 49kg close to usual adult weight, not engaging with eating disorder service as eating well. runs most days few km/d, 15km on Sunday Medication: Dexamphetamine tablets for adult ADHD Past history of depression resolved, no treatment currently Examination Well looking, Height 156cm, BMI = 20.1, blood pressure 96/63 mmhg, normal visual field

Case 4 Laboratory profile: Oestradiol <50 pmol/l Testosterone 0.6 nmol/l (normal <1.9) LH 0.7 IU/L, FSH 4.6 IU/L (low/normal) Prolactin 78 miu/l (normal) Other labs (FBC, U&E, LFT, CRP, TFT) entirely normal Diagnosis? Hypothalamic (functional) amenorrhoea

Case 4: management Efforts to gain further weight, reduce running mileage Oestrogen based treatment (rationale = bone protection + reduce low oestrogen symptoms) best evidence with transdermal oestrogen (Estradot patch), alternatively OCP or HRT type of regimen patient refused Bone density (DEXA) scan arranged

Lumbar spine T score -3.0, average total hips T scrore -2.8 FRAX 10-year hip fracture risk = 3% Diagnosis? Mx?

Case 4: Osteoporosis Mx Still refuses oestrogen but agrees to take risedronate (35mg p.o. weekly)! If she experiences dyspepsia/ significant reflux, what do we do? Other treatment options? Does she need vitamin D supplementation? What about calcium? What else would improve bone density? How long do we carry on with risedronate therapy? If repeat DEXA at 5 years shows minimal improvement what do we do then?

Case 5: Mr AE 47 y.o. NZ Pakeha male, presenting with low libido and erectile dysfunction, with slightly raised prolactin 296 miu/l (normal <240) Significant history of depression and anxiety on venlafaxine Considerable work stress (office work) no issues at home (2 teenage kids, good relationship with wife) Intermittent headaches, some degree of insomnia DDx? Futher history and exam?

Case 5 No other significant medical or pertinent family history Non smoker, non drinker, no recreational drugs Good appetite stable weight Blood test: - Prolactin mildly raised at 278 miu/l - Total testosterone mildly low at 7.7 nmol/l, with LH 2.9 and FSH 8.2 (within normal limits) - Other tests, including FBC, U&E, LFTs, TFT, cortisol, PSA normal

Case 5 Appears comfortable, normal male secondary sexual characteristics, raised BMI =30 Visual field normal on confrontation, testes normal volume but firm mobile lump superior aspect of L testis Testicular USS L epididymal cyst (1cm) MRI scan of the pituitary entirely normal Repeat morning testosterone 4.7 and 6.9 nmol/l

Case 5 Testosterone replacement (Reandron 1000 injection) started Referred to sleep clinic (history of loud snoring, high BMI, some daytime somnolence) For repeat PSA, FBC, review of possible OSA symptoms in 3-4 months

Thank you Questions?